New HPTN 052 study results reveal additional benefits of early HIV treatment
Study results released today by the HIV Prevention Trials Network (HPTN) show additional benefits of early antiretroviral therapy (ART) in HIV clinical outcomes. Expanded analysis of HPTN 052 study data, presented today at ...
HIV & AIDS
Jul 26, 2012 |
not rated yet |
0
Trial signals major milestone in hunt for new TB drugs
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two ...
Diseases, Conditions, Syndromes
Jul 23, 2012 |
not rated yet |
0
Young African women risk HIV infections from older men
Poverty drove single teenage mother Kate Mzungu to seek out a rich older man, who buys her food and pays for her housing in exchange for the pleasures of her young company.
HIV & AIDS
Jul 23, 2012 |
not rated yet |
0
Scientists call for increased surveillance as study assessing HIV drug resistance shows rising rates in Africa
New research published online first in the Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy nearly a decade ago.
HIV & AIDS
Jul 22, 2012 |
not rated yet |
0
Among new HIV treatment recommendations, all adult patients should be offered antiretroviral therapy
Included in the 2012 International Antiviral Society-USA panel recommendations for human immunodeficiency virus (HIV) patient care is that all adult patients, regardless of CD4 cell count, should be offered antiretroviral ...
HIV & AIDS
Jul 22, 2012 |
not rated yet |
0
Study implements community-based approach to treat HIV-infection in rural Uganda
New research from the University of Alberta's School of Public Health has demonstrated that community-based resources in rural Uganda can successfully provide HIV treatments to patients, where economic and geographical barriers ...
Health
Jul 19, 2012 |
not rated yet |
0
UN reports progress against HIV in poor countries
(AP) A push to get more AIDS treatment to the world's poorest, hardest-hit countries is paying off as deaths inch down and new infections are dropping a bit, too, the United Nations reported Wednesday.
HIV & AIDS
Jul 19, 2012 |
not rated yet |
0
HIV drug resistance creeps higher: WHO
Drug resistance to HIV medicines has been creeping higher in parts of Africa and Asia but is not steep enough to cause alarm, said a survey released by the World Health Organization on Wednesday.
HIV & AIDS
Jul 18, 2012 |
not rated yet |
0
Study uses novel incentive to encourage HIV patient care and treatment
In a new study by ICAP at Columbia's Mailman School of Public Health, researchers are assessing a novel approach to encourage newly diagnosed HIV positive people to seek care and adhere to HIV treatment. The unique study ...
HIV & AIDS
Jul 17, 2012 |
4 / 5 (1) |
0
Identifying risky behaviors: The key to HIV prevention
HIV prevention must be better targeted, according to David Holtgrave from Johns Hopkins Bloomberg School of Public Health in the US, and colleagues. Health care professionals need a more detailed analysis and understanding ...
HIV & AIDS
Jul 11, 2012 |
not rated yet |
0
Investigating the impact of treatment on new HIV infections: New PLoS collection
Is it possible to cut HIV transmission by using antiretroviral treatment? A collection of new articles published in the open-access journal PLoS Medicine, in conjunction with the HIV Modelling Consortium, addresses this p ...
HIV & AIDS
Jul 10, 2012 |
not rated yet |
0
Generic drugs key to US overseas HIV relief: researchers
The President's Emergency Plan for AIDS Relief (PEPfAR) began in 2003 with good intentions, but it was not until the U.S. government's massive overseas public health campaign adopted generic drugs that it became a success, ...
Medications
Jul 09, 2012 |
not rated yet |
0
New once-daily 'Quad' pill for HIV is safe, effective alternative to traditional antiretroviral regimens
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. ...
HIV & AIDS
Jun 28, 2012 |
not rated yet |
0
'War on drugs' is fueling HIV epidemic: report
A pressure group that includes six former presidents called Tuesday for the United Nations to acknowledge that "repressive drug law enforcement" was driving an HIV/AIDS pandemic.
HIV & AIDS
Jun 26, 2012 |
not rated yet |
0
Lessons learned from the 'ethical odyssey' of an HIV trial
In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve. The landmark HIV Prevention Trials Network (HPTN) 052 study, which established that antiretroviral ...
HIV & AIDS
Jun 14, 2012 |
5 / 5 (2) |
0